BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24475556)

  • 1. Role of gentian violet paint in burn wound management: a prospective randomised control trial.
    Choudhary KN; Soni PP; Sao DK; Murthy R; Deshkar AM; Nanda BR
    J Indian Med Assoc; 2013 Apr; 111(4):248-50. PubMed ID: 24475556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of topical Phenytoin with Silverex in the treatment of superficial dermal burn wounds.
    Carneiro PM; Rwanyuma LR; Mkony CA
    Cent Afr J Med; 2002; 48(9-10):105-8. PubMed ID: 14562531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moist Exposed Burn Ointment (MEBO) in partial thickness burns - a randomized, comparative open mono-center study on the efficacy of dermaheal (MEBO) ointment on thermal 2nd degree burns compared to conventional therapy.
    Hirsch T; Ashkar W; Schumacher O; Steinstraesser L; Ingianni G; Cedidi CC
    Eur J Med Res; 2008 Nov; 13(11):505-10. PubMed ID: 19073386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentian violet for pyoderma gangrenosum: a retrospective chart review.
    Stiff KM; Glines KR; Muse ME; Cline A; Feldman SR; Jorizzo JL; Huang WW
    Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of hydrocolloid SSD dressing in the outpatient management of partial thickness burns.
    Muangman P; Muangman S; Opasanon S; Keorochana K; Chuntrasakul C
    J Med Assoc Thai; 2009 Oct; 92(10):1300-5. PubMed ID: 19845237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gentian violet on refractory discharging ears infected with methicillin-resistant Staphylococcus aureus.
    Kayama C; Goto Y; Shimoya S; Hasegawa S; Murao S; Nakajo Y; Nibu K
    J Otolaryngol; 2006 Dec; 35(6):384-6. PubMed ID: 17380832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical gentian violet in dermatology.
    Bunker CB
    J Am Acad Dermatol; 2009 Feb; 60(2):347-8. PubMed ID: 19150283
    [No Abstract]   [Full Text] [Related]  

  • 8. Responsiveness of nonHerlitz junctional epidermolysis bullosa to topical gentian violet.
    Venugopal SS; Intong LR; Cohn HI; Mather-Hillon J; Murrell DF
    Int J Dermatol; 2010 Nov; 49(11):1282-5. PubMed ID: 20964648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the role of alternative therapy in burn wound management: randomized trial comparing moist exposed burn ointment with conventional methods in the management of patients with second-degree burns.
    Ang ES; Lee ST; Gan CS; See PG; Chan YH; Ng LH; Machin D
    MedGenMed; 2001 Mar; 3(2):3. PubMed ID: 11549952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of methylene blue and gentian violet dressing for management of chronic wounds with local infection.
    Woo KY; Heil J
    Int Wound J; 2017 Dec; 14(6):1029-1035. PubMed ID: 28508548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Treatment of Severe Tungiasis in Pigs Using a Topical Aerosol Containing Chlorfenvinphos, Dichlorphos and Gentian Violet.
    Mutebi F; von Samson-Himmelstjerna G; Feldmeier H; Waiswa C; Bukeka Muhindo J; Krücken J
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005056. PubMed ID: 27727268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical gentian violet for cutaneous infection and nasal carriage with MRSA.
    Okano M; Noguchi S; Tabata K; Matsumoto Y
    Int J Dermatol; 2000 Dec; 39(12):942-4. PubMed ID: 11168669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RCT on gentian violet versus a hydrogel dressing for radiotherapy-induced moist skin desquamation.
    Gollins S; Gaffney C; Slade S; Swindell R
    J Wound Care; 2008 Jun; 17(6):268-70, 272, 274-5. PubMed ID: 18666721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of hydrocolloid dressing and gentian violet on radiation-induced moist desquamation wound healing.
    Mak SS; Molassiotis A; Wan WM; Lee IY; Chan ES
    Cancer Nurs; 2000 Jun; 23(3):220-9. PubMed ID: 10851773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed primary closure of the burn wounds.
    Prasanna M; Mishra P; Thomas C
    Burns; 2004 Mar; 30(2):169-75. PubMed ID: 15019128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nitric acid burn trauma of the skin.
    Kolios L; Striepling E; Kolios G; Rudolf KD; Dresing K; Dörges J; Stürmer KM; Stürmer EK
    J Plast Reconstr Aesthet Surg; 2010 Apr; 63(4):e358-63. PubMed ID: 19875347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary study on the improvement of wound microcirculation and retrospection on several methods of the management of deep partial thickness burn wound].
    Sun YH; Yu DN; Chen X; Hu XH; Zhang GA; Yan RY; Tan FJ
    Zhonghua Shao Shang Za Zhi; 2005 Feb; 21(1):17-20. PubMed ID: 15796836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of improved topical agents on healing time of deep second-degree burn wound].
    Yang HM; Chai JK; Guo ZR
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 May; 15(3):162-4. PubMed ID: 11393958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of human recombinant growth hormone on donor-site healing in burned adults.
    Losada F; García-Luna PP; Gómez-Cía T; Garrido M; Pereira JL; Marín F; Astorga R
    World J Surg; 2002 Jan; 26(1):2-8. PubMed ID: 11898025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the use of gentian violet in dermatology practice.
    Pona A; Quan EY; Cline A; Feldman SR
    Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.